Biotech Biotech’s Monday Split: Two Trial Wins, One Trial Miss and an FDA Rejection November 16, 2026
Biotech Rakovina Therapeutics to Present ATR Inhibitor Data in PTEN-Deficient Prostate Cancer at the 38th EORTC-NCI-AACR Symposium November 16, 2026
Biotech Oculis Announces FDA IND Clearance Enabling Acceleration of Privosegtor Development Program in Acute Multiple Sclerosis Relapses November 16, 2026
Biotech Relmada Therapeutics Appoints Uro-Oncology Leader Jørn Skibsted Jakobsen, MD, PhD, as Chief Development Officer November 16, 2026
Biotech Evotec Secures $2.9 Million Grant to Advance Early Drug Safety Testing Using Human Stem Cell Technology November 16, 2026
Biotech Lexeo Therapeutics to Report Third Quarter 2026 Financial Results and Provide LX2020 Business Update on November 16, 2026 November 15, 2026
Biotech Cocrystal Pharma Provides Business Update and Reports Third Quarter 2026 Financial Results November 15, 2026
Biotech HUTCHMED Announces Expanded Coverage on National Reimbursement Drug List for ELUNATE® and ORPATHYS® November 15, 2026